This study investigates the use of an investigational medication in people with solid tumors and chronic lymphocytic leukemia (CLL). The purpose of this study is to explore how safe the medication is and how well it works for these conditions.
The study will focus on evaluating the safety, tolerability, and effectiveness of the investigational medication. Researchers will assess how the body processes the medication and its potential impact on the tumors.
- Who can participate: Adults aged 18 and older with solid tumors or CLL may participate. Participants must have a measurable disease. They also need to meet specific health criteria, including adequate organ function.
- Study details: Participants will receive the investigational medication through intravenous infusions in cycles. The study will monitor side effects and the medication's effects on the condition. An inactive substance that looks like the investigational medicine but does not contain any medicine may be used for comparison.
How understandable was the trial content above?
Hard to understand
Easy to understand